Israel
# |
Name |
Return on Assets (ROA) |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
2.33%
|
Dec. 31, 2023 | USD 6.96 | 3.55% |
|
Israel |
|
2 |
0.91%
|
Dec. 31, 2023 | USD 0.08 | 0.74% |
|
Israel |
|
3 |
-0.04%
|
Dec. 31, 2023 | USD 0.02 | -4.22% |
|
Israel |
|
4 |
-10.11%
|
Dec. 31, 2023 | USD 19.58 | -1.51% |
|
Israel |
|
5 |
-15.46%
|
Dec. 31, 2023 | USD 2.38 | 4.02% |
|
Israel |
|
6 |
-27.15%
|
Dec. 31, 2023 | USD 3.70 | -2.63% |
|
Israel |
|
7 |
-77.78%
|
Dec. 31, 2023 | USD 1.95 | 4.71% |
|
Israel |
|
8 |
-94.82%
|
Dec. 31, 2023 | USD 0.01 | -3.84% |
|
Israel |
|
9 |
-116.08%
|
Dec. 31, 2023 | USD 0.11 | 3.21% |
|
Israel |
The Clinical Trials company in Israel with the highest Return on Assets (ROA) is Kamada Ltd. (Tel Aviv Stock Exchange: KMDA.TA) at 2.33%.
The Clinical Trials company in Israel with the lowest Return on Assets (ROA) is Tikun Olam-Cannbit Pharmaceuticals Ltd (Tel Aviv Stock Exchange: TKUN.TA) at -116.08%.
The top 10 Clinical Trials companies in Israel by Return on Assets (ROA) are Kamada Ltd., Bio-View Ltd, Purple Biotech Ltd., MediWound Ltd., Compugen Ltd., Alpha Tau Medical Ltd., BioLight Life Sciences Ltd., BioLineRx Ltd. and Tikun Olam-Cannbit Pharmaceuticals Ltd.
The bottom 10 Clinical Trials companies in Israel by Return on Assets (ROA) are Tikun Olam-Cannbit Pharmaceuticals Ltd, BioLineRx Ltd., BioLight Life Sciences Ltd., Alpha Tau Medical Ltd., Compugen Ltd., MediWound Ltd., Purple Biotech Ltd., Bio-View Ltd and Kamada Ltd..